Ignite Creation Date:
2025-12-24 @ 10:43 PM
Ignite Modification Date:
2026-01-01 @ 11:58 AM
Study NCT ID:
NCT01782235
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2013-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
Sponsor:
University Hospital, Strasbourg, France
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
5206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None